Literature DB >> 2905880

Duplication of HRAS1, INS, and IGF2 is not a common event in Beckwith-Wiedemann syndrome.

I Henry1, M Jeanpierre, F Barichard, J L Serre, J Mallet, C Turleau, J de Grouchy, C Junien.   

Abstract

A few cases of Beckwith-Wiedemann syndrome (BWS) have in common a duplication of 11p15. Among the genes located in 11p15, c-Ha-ras 1 (HRAS1), insulin (INS), and insulin-like growth factor II (IGF2) may account for the clinical features and the increased risk for malignancy. Using eight 11p15 markers including HRAS1, INS and IGF2 we have studied eight sporadic and hereditary cases of BWS whether or not associated with a nephroblastoma. By gene dosage determination and family studies, we have shown the following: the eight patients examined had an apparent diploid representation of all of the eight markers studied, thus indicating that a microduplication of these markers or of the region characterized by these markers is not a common event in BWS; in a family with three affected sibs the genes for HRAS1 and INS/IGF2 did not cosegregate with BWS and therefore may not participate in the pathogenic processes here observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905880

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  3 in total

1.  Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome.

Authors:  D Viljoen; R Ramesar
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

2.  Congenital hyperinsulinism and mosaic abnormalities of the ploidy.

Authors:  I Giurgea; D Sanlaville; J-C Fournet; C Sempoux; C Bellanné-Chantelot; G Touati; L Hubert; M-S Groos; F Brunelle; J Rahier; J-C Henquin; M J Dunne; F Jaubert; J-J Robert; C Nihoul-Fékété; M Vekemans; C Junien; P de Lonlay
Journal:  J Med Genet       Date:  2005-07-20       Impact factor: 6.318

Review 3.  What's new in metabolic and genetic hypoglycaemias: diagnosis and management.

Authors:  Vassili Valayannopoulos; Stéphane Romano; Karine Mention; Anne Vassault; Daniel Rabier; Michel Polak; Jean-Jacques Robert; Yves de Keyzer; Pascale de Lonlay
Journal:  Eur J Pediatr       Date:  2007-10-03       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.